Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration

To evaluate the functional and anatomical effects of switching to faricimab for patients with neovascular age-related macular degeneration (nAMD) refractory to intravitreal aflibercept, this retrospective study evaluated patients with nAMD who received intravitreal injections of aflibercept (IVA) ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Maya, Miki, Akiko, Kamimura, Aya, Okuda, Mina, Matsumiya, Wataru, Imai, Hisanori, Kusuhara, Sentaro, Nakamura, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419383/
https://www.ncbi.nlm.nih.gov/pubmed/37568546
http://dx.doi.org/10.3390/jcm12155145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419383/
https://www.ncbi.nlm.nih.gov/pubmed/37568546
http://dx.doi.org/10.3390/jcm12155145

Ejemplares similares